Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

Cell

Volumn 88, Issue 4, 1997, Pages 553-560

  Goldman, Mitchell J ^a   Anderson, G Mark ^b   Stolzenberg, Ethan D ^b   Kari, U Prasad ^b   Zasloff, Michael ^b   Wilson, James M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Genaera Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DEFENSIN; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; CYSTIC FIBROSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY SYSTEM; XENOGRAFT;

EID: 0030949875     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81895-4     Document Type: Article

References (37)

1. Armstrong, D.S., Grimwood, K., Carzino, R., Carlin, J.B., Olinsky, A., and Phelan, P.D. (1995). Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Br. Med. J. 310, 1571-1572.
2. Armstrong, D.S., Grimwood, K., and Carlin, J.H.B. (1996). Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr. Pulmonol. 21, 267-275.
3. Bensch, K.W., Raida, M., Magert, H.-J., Schulz-Knappe, P., and Forssmann, W.-G. (1995). hBD-1: a novel β-defensin from human plasma. FEBS Lett. 368, 331-335.
4. Boucher, R.C. (1994). Human airway ion transport (part one). Am. J. Respir. Crit. Care Med. 150, 271-281.
5. Cheng, P.-W., Boat, T.F., Cranfill, K., Yankaskas, J.R., and Boucher, R.C. (1989). Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J. Clin. Invest. 84, 68-72.
6. Diamond, G., Zasloff, M., Eck, H., Brasseur, M., Maloy, W.L., and Bevins, C.L. (1991). Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. USA 88, 3952-3956.
7. Diamond, G., Russell, J.P.,and Bevins, C.L. (1996). Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc. Natl. Acad. Sci. USA 93, 5156-5150.
8. Eisenhauer, P.B., and Lehrer, R.I. (1992). Mouse neutrophils lack defensins. Infect. Immun. 60, 3446-3447.
9. Engelhardt, J., Yankaskas, J., Ernst, S., Yang, Y., Marino, C., Boucher, R., Cohn, J., and Wilson, J. (1992a). Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nature Genet. 2, 240-248.
10. Engelhardt, J.F., Yankaskas, J.R., and Wilson, J.M. (1992b). In vivo retroviral gene transfer into human bronchial epithelia of xenografts. J. Clin. Invest. 90, 2598-2607.
11. Engelhardt, J., Yang, Y., Stratford-Perricaudet, L., Allen, E., Kozarsky, K., Perricaudet, M., Yankaskas, J., and Wilson, J. (1993a). Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1 -deleted adenoviruses. Nature Genet. 4, 27-34.
12. Engelhardt, J., Simon, R., Yang, Y., Zepeda, M., Pendleton, S., Doranz, B., Grossman, M., and Wilson, J. (1993b). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Thera. 4, 759-769.
13. Engelhardt, J.F., Schlossberg, H., Yankaskas, J.R., and Dudus, L. (1995). Progenitor cells of the adult human airway involved in submucosal gland development. Development 127, 2031-2046.
14. Frohman, M.A., Dush, M.K., and Martin, G.R. (1988). Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85, 8995-9002.
15. Fuchs, HJ., Borowitz, D.S., Christiansen, D.H., Morris, E.M., Nash, M.L., Ramsey, B.W., Rosenstein, B.J., Smith, A.L., and Wohl, M.E. (1994). Effect of aerosolized recombinant human dNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. New Eng. J. Med. 337, 637-642.
16. Ganz, T., and Lehrer, R.I. (1994). Defensins. Curr. Opin. Immunol. 6, 584-589.
17. Ganz, T., and Lehrer, R.I. (1995). Defensins. Pharmac. Ther. 66, 191-205.
18. Gilljam, H., Ellin, A., and Strandvik, B. (1989). Increased bronchial chloride concentration in cystic fibrosis. Scand. J. Clin. Lab. Invest. 49, 121-124.
19. Goldman, M., Yang, Y., and Wilson, J. (1995). Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nat. Genet. 9, 126-131.
20. Harwig, S.S.L., Ganz, T., and Lehrer, R.I. (1994). Neutrophil defensins: purification, characterization, and antimicrobial testing. Meth. Enzymol. 236, 160-172.
21. Huttner, K.M., Selsted, M.E., and Ouellette, A.J. (1994). Structure and diversity of the murine cryptdin gene family. Genomics 19, 448-453.
22. Jones, D.E., and Bevins, C.L. (1992). Paneth cells of the human small intestine express an antimicrobial peptide gene. J. Biol. Chem. 267, 23216-23225.
23. Jones, D.E., and Bevins, C.L. (1993). Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett. 315, 187-192.
24. Joris, L., Dab, I., and Quinton, P.M. (1993). Elemental composition of human airway surface fluid in healthy and diseased airways. Am. Rev. Respir. Dis. 148, 1633-1637.
25. Kellenberger, C., Heitter, H., and Lu, B. (1995). Regioselective formation of the three disulfide bonds of a 35-residue insect peptide. Peptide Res. 8, 321-327.
26. Mallow, E.B., Harris, A., Salzman, N., Russell, J.P., DeBerardinis, R.J., Ruchelli, E., and Bevins, C. (1996). Human enteric defensins. J. Biol. Chem. 271, 4038-4045.
27. Ouellette, A.J., Greco, R.M., James, M., and Frederick, D. (1989). Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J. Cell Biol. 108, 1687-1695.
28. Pier, G.B., Grout, M., Saidi, T.S., Olsen, J.C., Johnson, L.G., Yankaskas, J.R., and Goldberg, J.B. (1996). Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271, 64-67.
29. Quinton (1983). Chloride impermeability in cystic fibrosis. Nature 307, 421-422.
30. Russell, J.P., Diamond, G., Tarver, A.P., Scanlin, T.F., and Bevins, C.L. (1996). Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha. Infect. Immun. 64, 1565-1568.
31. Schonwetter, B.S., Stolzenberg, E.D., and Zasloff, M.A. (1995). Epithelial antibiotics induced at sites of inflammation. Science 267, 1645-1648.
32. Smith, J.J., Travis, S.M., Greenberg, E.P., and Welsh, M.J. (1996). Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229-236.
33. Tang, H., Kay, M., and Prince, A. (1995). Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63, 1278-1285.
34. Vasconcellos, C.A., Allen, P.G., Wohl, M.E., Drazen, J.M., Janmey, P.A., and Stossel, T.P. (1994). Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263, 969-971.
35. Welsh, M.J.,Tsui, L.-C., Boat, T.F., and Beaudet, A.L. (1995). Cystic fibrosis. In The Metabolic and Molecular Bases of Inherited Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds. (New York: McGraw-Hill Inc.), pp. 3799-3876.
36. Willumsen, N.J., and Boucher, R.C. (1991). Transcellular sodium transport in cultures cystic fibrosis human nasal epithelium. Am. J. Physiol. 30, C332-C341.
37. Zhang, Y., Yankaskas, J.R., Wilson, J.M.,and Engelhardt, J.F. (1996). In vivo analysis of fluid transport in cystic fibrosis airway epithelia of bronchial xenografts. Am. J. Physiol. 270, C1326-1335.